Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Margaretta Nyilas"'
Autor:
J. Corey Fowler, Taisa Skubiak, Kirsten Engelhardt, Benjamin Furst, Sophia Zhao, Margaretta Nyilas, Debbie Profit, William Carson
Publikováno v:
Journal of Scientific Innovation in Medicine, Vol 4, Iss 1 (2021)
Objective:Adding to existing challenges in conducting clinical trials, COVID-19 has indefinitely affected modern clinical research. Decentralized clinical trials, using telemedicine and digital technology, may prove critical to the future of clinical
Externí odkaz:
https://doaj.org/article/6ae4dad627b441dd9d7fce83a35c887b
Autor:
Benjamin Furst, William H. Carson, Kirsten Engelhardt, Margaretta Nyilas, Sophia Zhao, Taisa Skubiak, J. Corey Fowler, Debbie Profit
Publikováno v:
Journal of Scientific Innovation in Medicine, Vol 4, Iss 1 (2021)
Objective: Adding to existing challenges in conducting clinical trials, COVID-19 has indefinitely affected modern clinical research. Decentralized clinical trials, using telemedicine and digital technology, may prove critical to the future of clinica
Autor:
Margaretta Nyilas, Robert D. McQuade, Joan Zhao, Floyd R. Sallee, Alet van Beek, Kevin Cox, Eva Kohegyi, Roger Kurlan, Raymond Sanchez, William H. Carson
Publikováno v:
Journal of Child and Adolescent Psychopharmacology
Objectives: Aripiprazole modulates dopaminergic and serotonergic pathways that may play a role in the pathogenesis of Tourette's disorder (TD). This trial evaluated the efficacy and safety of oral aripiprazole in the suppression of tics in children a
Autor:
Peter Hertel, Joan Amatniek, Pamela Perry, B. Johnson, Kevin Cox, Raymond Sanchez, Margaretta Nyilas, Robert D. McQuade, Joseph R. Calabrese, William H. Carson, Pedro Such, Na Jin
Publikováno v:
Journal of affective disorders. 241
Background Aripiprazole once-monthly 400 mg (AOM 400), an atypical long-acting injectable antipsychotic, has demonstrated efficacy and safety in maintenance treatment of bipolar I disorder (BP-I). We further assess safety and tolerability and charact
Autor:
Hans Eriksson, Aleksandar Skuban, William H. Carson, Michael E. Thase, Mary Hobart, Margaretta Nyilas, Raymond Sanchez, Robert D. McQuade, James M. Youakim, Peter Zhang
Publikováno v:
The Journal of Clinical Psychiatry. 76:1232-1240
Objective To evaluate efficacy, safety, and tolerability of brexpiprazole adjunctive to antidepressant treatments (ADTs) in patients with major depressive disorder (as defined by DSM-IV-TR criteria) with inadequate response to ADTs. Method Patients s
Autor:
Robert D. McQuade, Stephanie Pfister, Aleksandar Skuban, William H. Carson, Hans Eriksson, John M. Kane, John Ouyang, Margaretta Nyilas, Raymond Sanchez, Mary Hobart
Publikováno v:
Schizophrenia Research. 164:127-135
The objective of this study was to evaluate the efficacy, safety and tolerability of brexpiprazole versus placebo in adults with acute schizophrenia. This was a 6-week, multicenter, placebo-controlled double-blind phase 3 study. Patients with acute s
Autor:
Robert D. McQuade, N. Jin, Kevin Cox, Pamela Perry, Margaretta Nyilas, Pedro Such, Raymond Sanchez, B. Johnson, William H. Carson, Joseph R. Calabrese, Joan Amatniek, Peter Hertel
Publikováno v:
Journal of affective disorders. 227
Background Effects of maintenance treatment with aripiprazole once-monthly 400 mg (AOM 400) on symptoms and functioning were assessed in adults with bipolar I disorder (BP-I) after a manic episode. Methods Patients were stabilized on oral aripiprazol
Autor:
Robert D. McQuade, William H. Carson, Phyllis M. Salzman, Eva Kohegyi, Margaretta Nyilas, Christoph U. Correll, Raymond Sanchez, Ross A. Baker, Cathy Zhao
Publikováno v:
Journal of the American Academy of Child and Adolescent Psychiatry. 56(9)
Objective To evaluate the efficacy, safety, and tolerability of aripiprazole, a dopamine D 2 receptor partial agonist, as maintenance treatment in adolescent outpatients with schizophrenia. Method This was a multicenter, double-blind, placebo-control
Autor:
Christoph U. Correll, Gabrielle A. Carlson, Robert A. Forbes, Robert L. Findling, William H. Carson, Robert D. McQuade, N. Jin, Margaretta Nyilas, Raymond Mankoski, Svetlana Ivanova
Publikováno v:
Bipolar Disorders. 15:138-149
Objective: To evaluate the long-term efficacy, safety, and tolerability of aripiprazole in pediatric subjects with bipolar I disorder. Methods: A randomized, double-blind, 30-week, placebo-controlled study of aripiprazole (10 or 30 mg/day) in youths
Autor:
Peter Hertel, Pamela Perry, Robert D. McQuade, N. Jin, Phyllis M. Salzman, William H. Carson, Pedro Such, Margaretta Nyilas, Kevin Cox, Joan Amatniek, Raymond Sanchez, Joseph R. Calabrese, B. Johnson
Publikováno v:
The Journal of clinical psychiatry. 78(3)
To evaluate efficacy, safety, and tolerability of long-acting injectable antipsychotic aripiprazole once-monthly 400 mg (AOM 400) as maintenance treatment for bipolar I disorder (BP-I).In a double-blind, placebo-controlled, 52-week randomized withdra